Production, purification, characterization, immobilization, and application of Serrapeptase: a review

Abstract

Background

Serrapeptase is a proteolytic enzyme with many favorable biological properties like anti-inflammatory, analgesic, anti-bacterial, fibrinolytic properties and hence, is widely used in clinical practice for the treatment of many diseases. Although Serrapeptase is widely used, there are very few published papers and the information available about the enzyme is very meagre. Hence this review article compiles all the information about this important enzyme Serrapeptase.

Methods

A literature search against various databases and search engines like PubMed, SpringerLink, Scopus etc. was performed.

Results

We gathered and highlight all the published information regarding the molecular aspects, properties, sources, production, purification, detection, optimizing yield, immobilization, clinical studies, pharmacology, interaction studies, formulation, dosage and safety of the enzyme Serrapeptase.

Conclusion

Serrapeptase is used in many clinical studies against various diseases for its anti-inflammatory, fibrinolytic and analgesic effects. There is insufficient data regarding the safety of the enzyme as a health supplement. Data about the antiatherosclerotic activity, safety, tolerability, efficacy and mechanism of action of the Serrapeptase are still required.

This is a preview of subscription content, access via your institution.

References

  1. Abdou A M (2003). Purification and partial characterization of psychrotrophic Serratia marcescens lipase. J Dairy Sci, 86(1): 127–132

    CAS  PubMed  Article  Google Scholar 

  2. Ahmed H H, Fadl N N, El-Shamy K A, Hamza H A (2014). Miracle enzymes serrapeptase and nattokinase mitigate neuroinflammation and apoptosis associated with Alzheimer’s disease in experimental model. World J Pharm Pharm Sci, 3(2): 876–891

    Google Scholar 

  3. Aiyappa P S, Harris J O (1976). The extracellular metalloprotease of Serratia marcescens: I. Purification and characterization. Mol Cell Biochem, 13(2): 95–100

    CAS  PubMed  Article  Google Scholar 

  4. Al-Khateeb T H, Nusair Y (2008). Effect of the proteolytic enzyme serrapeptase on swelling, pain and trismus after surgical extraction of mandibular third molars. Int J Oral Maxillofac Surg, 37(3): 264–268

    CAS  PubMed  Article  Google Scholar 

  5. Aldridge S (2013). Industry backs biocatalysis for greener manufacturing. Nat Biotechnol, 31(2): 95–96

    CAS  PubMed  Article  Google Scholar 

  6. Ambrus J L, Lassman H B, DeMarchi J J (1967). Absorption of exogenous and endogenous proteolytic enzymes. Clin Pharmacol Ther, 8(3): 362–368

    CAS  PubMed  Article  Google Scholar 

  7. Ammar M S, El-Ssaway M, Yassin M, Sherif Y M (1998). Hydrolytic Enzymes of fungi isolated from Certain Egyptian Antiquities objects while utilizing the Industrial Wastes of Sugar and Integrated Industries Company (SIIC). Egypt J Biotechnol, (3): 60–90

    CAS  Google Scholar 

  8. Anil C S, Kashinath M A (2013). Production, Characterization and optimization of potent protease (Serratiopeptidase) from SerratiamarcescensE 15. Int Res J Pharm App Sci, 3(4): 95–98

    Google Scholar 

  9. Aratani H, Tateishi H, Negita S (1980). Studies on the distributions of antibiotics in the oral tissues: Experimental staphylococcal infection in rats, and effect of serratiopeptidase on the distributions of antibiotics (author’s transl). Jpn J Antibiot, 33(5): 623–635

    CAS  PubMed  Google Scholar 

  10. Aso T, Noda Y, Matsuura S, Nishimura T (1981). Breast engorgement and its treatment: Clinical effects of Danzen an anti-inflammatory enzyme preparation. The world of Obsttrics and Gynecology (Japanese), 33: 371–379

    Google Scholar 

  11. Ayswarya A, Ramesh B, Muthuraman M S (2013). Optimisation studies in the production and purification of serratiopeptidase from Serratiamarscecens UV mutant SM3. International Journal of Pharmacy and Pharmaceutical Sciences, 5(3): 0975–1491

    Google Scholar 

  12. Bach E, Anna S V, Daroit D J, Correa A P F, Segalin J, Brandelli A (2012). Production, one-step purification, and characterization of a keratinolytic protease from Serratia marcescens P3. Process Biochem, 47(12): 2455–2462

    CAS  Article  Google Scholar 

  13. Badhe R V, Nanda R K, Kulkarni M B, Bhujabal M N, Patil P S, Badhe S R (2009). Medium optimization studies for Serratiopeptidase production from Serratia marcescens ATCC 13880. Hindustan Antibiotics Bulletin, 51(1–4): 17–23

    PubMed  Google Scholar 

  14. Baumann U (1994). Crystal structure of the 50 kDa metallo protease from Serratia marcescens. J Mol Biol, 242(3): 244–251

    CAS  PubMed  Article  Google Scholar 

  15. Bellussi L, Ciferri G, De S E, Passali D (1984). Effect of 2-(alphathenoylthio) propionyl-glycine in treatment of secretory otitis media. CurrTher Res, 36(3): 596–605

    Google Scholar 

  16. Bhagat S, Agarwal M, Roy V (2013). Serratiopeptidase: a systematic review of the existing evidence. Int J Surg, 11(3): 209–217

    PubMed  Article  Google Scholar 

  17. Bi F, Zhang J, Su Y, Tang Y C, Liu J N (2009). Chemical conjugation of urokinase to magnetic nanoparticles for targeted thrombolysis. Biomaterials, 30(28): 5125–5130

    CAS  PubMed  Article  Google Scholar 

  18. Bodhankar M M, Agnihotri V V, Bhushan S B (2011). Feasibility, formulation and characterization of innovative microparticles for oral delivery of peptide drug. Int J Res Pharm Chem, 1(3): 630–636

    CAS  Google Scholar 

  19. Bracale G, Selvetella L (1996). Clinical study of the efficacy of and tolerance to seaprose S in inflammatory venous disease. Controlled study versus serratio-peptidase. Minerva Cardioangiol, 44(10): 515–524

    CAS  PubMed  Google Scholar 

  20. Braunagel S C, Benedik M J (1990). The metalloprotease gene of Serratia marcescens strain SM6. Mol Gen Genet, 222(2-3): 446–451

    CAS  PubMed  Article  Google Scholar 

  21. Cech T R, Bass B L (1986). Biological catalysis by RNA. Annu Rev Biochem, 55(1): 599–629

    CAS  PubMed  Article  Google Scholar 

  22. Celik M M, Kavvasoglu G, Celik E, Bulgurcu M (2013). Serratiopeptidase Induced Hemorrhage in a Patient with Behçet’s Disease. International Journal of Basic and Clinical Studies, 1(1): 190–196

    Google Scholar 

  23. Chen Y, Zhang Y (2011). Fluorescent quantification of amino groups on silica nanoparticle surfaces. Anal Bioanal Chem, 399(7): 2503–2509

    CAS  PubMed  Article  Google Scholar 

  24. Chopra D, Rehan H S, Mehra P, Kakkar A K (2009). A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction pain model. Int J Oral Maxillofac Surg, 38(4): 350–355

    CAS  PubMed  Article  Google Scholar 

  25. Decedue C J, Broussard E A 2nd, Larson A D, Braymer H D (1979). Purification and characterization of the extracellular proteinase of Serratia marcescens. Biochim Biophys Acta, 569(2): 293–301

    CAS  PubMed  Article  Google Scholar 

  26. Devi C S, Joseph R E, Saravanan H, Naine S J, Srinivansan V M (2013). Screening and molecular characterization of Serratia marcescens VITSD2: A strain producing optimum serratiopeptidase. Front Biol, 8(6): 632–639

    CAS  Article  Google Scholar 

  27. Dhanvijay P, Misra A K, Varma S K (2013). Diclofenac induced acute renal failure in a decompensated elderly patient. J Pharmacol Pharmacother, 4(2): 155–157

    PubMed  PubMed Central  Article  Google Scholar 

  28. Dohmen K, Matsunaga K, Irie K, Shirahama M, Onohara S, Miyamoto Y, Takeshita T, Ishibashi H (1998). Granulomatous hepatitis induced by saridon and serrapeptase. Hepatol Res, 11(2): 133–137

    Article  Google Scholar 

  29. El-Hamid H S, Ahmed H A, Sadek K M, El-Bestawy A R, Ellakany H F (2014). Impact of Serratiopeptidase treatment on performance and health parameters in broiler chicken. Int J Pharm Sci Rev Res, 26(2): 84–90

    Google Scholar 

  30. Esch P M, Gerngross H, Fabian A (1989). Reduction of postoperative swelling. Objective measurement of swelling of the upper ankle joint in treatment with serrapeptase–a prospective study. Fortschr Med, 107(4): 67–68, 71–72

    CAS  PubMed  Google Scholar 

  31. Fadl N N, Ahmed H H, Booles H F, Sayed A H (2013). Serrapeptase and nattokinase intervention for relieving Alzheimer’s disease pathophysiology in rat model. Hum Exp Toxicol, 32(7): 721–735

    CAS  PubMed  Article  Google Scholar 

  32. Garg R, Aslam A, Garg A, Walia R (2012). A prospective comparative study of serratiopeptidase and aceclofenac in upper and lower limb soft tissue trauma cases. Int J PharmacolPhamaceutTechnol, 1(2): 11–16

    Google Scholar 

  33. Gerber N N (1975). Prodigiosin-like pigments. CRC Crit Rev Microbiol, 3(4): 469–485

    CAS  PubMed  Article  Google Scholar 

  34. Gurung N, Ray S, Bose S, Rai V (2013). A broader view: microbial enzymes and their relevance in industries, medicine, and beyond. BioMed Res Int, 2013: 329121

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  35. Guyton A (1974). Function of the Human Body. WB Saunders, 4:8384

    Google Scholar 

  36. Hamada K, Hata Y, Katsuya Y, Hiramatsu H, Fujiwara T, Katsube Y (1996). Crystal structure of Serratia protease, a zinc-dependent proteinase from Serratia sp. E-15, containing a beta-sheet coil motif at 2.0 A resolution. J Biochem, 119(5): 844–851

    CAS  PubMed  Article  Google Scholar 

  37. Illanes A, Cauerhff A, Wilson L, Castro G R (2012). Recent trends in biocatalysis engineering. Bioresour Technol, 115(1): 48–57

    CAS  PubMed  Article  Google Scholar 

  38. Ishihara Y, Kitamura S, Takaku F (1983). Experimental studies on distribution of cefotiam, a new beta-lactam antibiotic, in the lung and trachea of rabbits. II. Combined effects with serratiopeptidase. Jpn J Antibiot, 36(10): 2665–2670

    CAS  PubMed  Google Scholar 

  39. Jadav S P, Patel N H, Shah T G, Gajera M V, Trivedi H R, Shah B K (2010). Comparison of anti-inflammatory activity of serratiopeptidase and diclofenac in albino rats. J Pharmacol Pharmacother, 1(2): 116–117

    PubMed  PubMed Central  Article  Google Scholar 

  40. Jayaratne P (1996). Major metalloprotease gene of Serratia marcescens is conserved and provides a molecular typing method to differentiate clinical isolates. J Microbiol Methods, 26(3): 261–269

    CAS  Article  Google Scholar 

  41. Jickling G C, Zhan X, Ander B P, Turner R J, Stamova B, Xu H, Tian Y, Liu D, Davis R R, Lapchak P A, Sharp F R (2010). Genome response to tissue plasminogen activator in experimental ischemic stroke. BMC Genomics, 11(1): 254

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  42. Jordon D L (1929). Red heat in salted hides. J IntSoc Leather Trade Chem, 13: 538–569

    Google Scholar 

  43. Juhi K P, Divya T, Mandev B P (2015). Development and Validation of Analytical Method for Estimation of Paracetamol, Lornoxicam and Serratiopeptidase in their Combined Dosage Form. J Pharm Sci Bioscientific Res, 5(5): 425–433

    Google Scholar 

  44. Kaisheng Y I N, Wanzhen F U, Lixian H E, Shanqun L I, Yi S H I, Yongying X I A O, Hao Y U, Zhenjie H A N (2000). A multicenter randomized double blind and controlled clinical trial of serrapeptase enteric coated tablets as an expectorant. Chinese journal of new Drugs and Clinical Remedies, 15(10): 737–740

    Google Scholar 

  45. Kamini N R, Hemchander C, Geraldine J (1999). Microbial enzyme technology as an alternative to conventional chemical in leather industry. Curr Sci, 76: 101

    Google Scholar 

  46. Kasé Y, Seo H, Oyama Y, Sakata M, Tomoda K, Takahama K, Hitoshi T, Okano Y, Miyata T (1982). A new method for evaluating mucolytic expectorant activity and its application.I. Methodology. Arzneimittelforschung, 32(4): 368–373

    PubMed  Google Scholar 

  47. Kaviyarasi N S, Prashantha C N, Suryanarayan V V S (2016). In Silico Analysis Of inhibitor and substrate binding site of serrapeptidase from SerratiamarcescensMTCC 8708. Int J Pharm Pharm Sci, 8(4): 975–1491

    Google Scholar 

  48. Kaviyarasi N S, Sarkar S, Suryanarayan V V S (2015). Characterization of a Gene Encoding Serrapeptidase from SerratiamarcescensStrain (SRM) MTCC 8708, a Plant Isolate. Int J Curr Microbiol Appl Sci, 4 (8): 206–214

    Google Scholar 

  49. Kaviyarasi N S, Suryanarayan V V S (2016). Serrapeptidase gene of Serratia marcescens from plant origin expressed by Pichia pastoris has protease activity. Indian Journal of Medical Research and Pharmaceutical Sciences, 3(6): 2349–5340

    Google Scholar 

  50. Kee W H, Tan S L, Lee V, Salmon Y M (1989). The treatment of breast engorgement with Serrapeptase (Danzen): a randomised double-blind controlled trial. Singapore Med J, 30(1): 48–54

    CAS  PubMed  Google Scholar 

  51. Klein G, Kullich W(2000). Short-term treatment of painful osteoarthritis of the knee with oral enzymes: randomised, double blind study versus Diclofenac. Clin Drug Investig, 19(1): 15–23

    CAS  Article  Google Scholar 

  52. Kloepper J W, Tuzun S, Liu L, Wei G (1993). Plant growth-promoting rhizobacteria as inducers of systemic disease resistance. In: Lumsden RD, Waughn J (eds) Pest management: biologically based technologies, American Chemical Society Books,156–165

  53. Koyama A, Mori J, Tokuda H, Waku M, Anno H, Katayama T, Murakami K, Komatsu H, Hirata M, Arai T (1986). Augmentation by serrapeptase of tissue permeation by cefotiam. Jpn J Antibiot, 39 (3): 761–771

    CAS  PubMed  Google Scholar 

  54. Krukemeyer M G, Krenn V, Jakobs M, Wagner W (2012). Magnetic drug targeting in a rhabdomyosarcoma rat model using magnetitedextran composite nanoparticle-bound mitoxantrone and 0.6 tesla extracorporeal magnets-sarcoma treatment in progress. J Drug Target, 20(2): 185–193

    CAS  PubMed  Article  Google Scholar 

  55. Kumar S, Jana A K, Dhamija I, Singla Y, Maiti M (2013). Preparation, characterization and targeted delivery of serratiopeptidase immobilized on amino-functionalized magnetic nanoparticles. Eur J Pharm Biopharm, 85(3 Pt A 3A): 413–426

    CAS  PubMed  Article  Google Scholar 

  56. Kumar S, Jana A K, Maiti M, Dhamija I (2014). Carbodiimide-mediated immobilization of serratiopeptidase on amino-, carboxyl-functionalized magnetic nanoparticles and characterization for target delivery. J Nanopart Res, 16(2): 2233

    Article  CAS  Google Scholar 

  57. Kumar S, Mohan U, Kamble A L, Pawar S, Banerjee U C (2010). Crosslinked enzyme aggregates of recombinant Pseudomonas putida nitrilase for enantioselective nitrile hydrolysis. Bioresour Technol, 101(17): 6856–6858

    CAS  PubMed  Article  Google Scholar 

  58. Létoffé S, Delepelaire P, Wandersman C (1991). Cloning and expression in Escherichia coli of the Serratia marcescens metalloprotease gene: secretion of the protease from E. coli in the presence of the Erwinia chrysanthemi protease secretion functions. J Bacteriol, 173(7): 2160–2166

    PubMed  PubMed Central  Article  Google Scholar 

  59. Liver Doctor (2013). Serrapeptase Health guide

    Google Scholar 

  60. Lowry O H, Rosebrough N J, Farr A L, Randall R J (1951). Protein measurement with the Folin phenol reagent. J Biol Chem, 193(1): 265–275

    CAS  PubMed  Google Scholar 

  61. Majima Y, Inagaki M, Hirata K, Takeuchi K, Morishita A, Sakakura Y (1988). The effect of an orally administered proteolytic enzyme on the elasticity and viscosity of nasal mucus. Arch Otorhinolaryngol, 244(6): 355–359

    CAS  PubMed  Article  Google Scholar 

  62. Malshe P C (2000). A preliminary trial of serratiopeptidase in patients with carpal tunnel Syndrome. J Assoc Physicians India, 48(11): 1130

    CAS  PubMed  Google Scholar 

  63. Manal K M (2015). Effect of temperature and mutation on serratiopeptidase secreted from Serratiamarcesence. Journal of Genetic and Environmental Resources Conservation, 3(1): 35–37

    Google Scholar 

  64. Matsumoto K, Maeda H, Takata K, Kamata R, Okamura R (1984). Purification and characterization of four proteases from a clinical isolate of Serratia marcescens kums 3958. J Bacteriol, 157(1): 225–232

    CAS  PubMed  PubMed Central  Google Scholar 

  65. Mazzone A, Catalani M, Costanzo M, Drusian A, Mandoli A, Russo S, Guarini E, Vesperini G (1990). Evaluation of Serratia peptidase in acute or chronic inflammation of otorhinolaryngology pathology: a multicentre, double-blind, randomized trial versus placebo. J Int Med Res, 18(5): 379–388

    CAS  PubMed  Article  Google Scholar 

  66. Mecikoglu M, Saygi B, Yildirim Y, Karadag-Saygi E, Ramadan S S, Esemenli T (2006). The effect of proteolytic enzyme serratiopeptidase in the treatment of experimental implant-related infection. J Bone Joint Surg Am, 88(6): 1208–1214

    PubMed  Article  Google Scholar 

  67. Metkar S K, Girigoswami A, Murugesan R, Girigoswami K (2016). In vitro and in vivo insulin amyloid degradation mediated by Serratiopeptidase. Materials Science & Engineering C, 70(2017): 728–735

    Google Scholar 

  68. Miyagawa S, Matsumoto K, Kamata R, Okamura R, Maeda H (1991). Spreading of Serratia marcescens in experimental keratitis and growth suppression by chicken egg white ovomacroglobulin. Jpn J Ophthalmol, 35(4): 402–410

    CAS  PubMed  Google Scholar 

  69. Miyata K, Maejima K, Tomoda K, Isono M(1970). Serratia protease part1. Purification and general properties of the enzyme. AgrBiolChem, 34(2): 310–318

    CAS  Google Scholar 

  70. Miyata K, Tomoda K, Isono M (1970b). Serratia protease. Part II. Substrate specificity of the enzyme. Agric Biol Chem, 34(10): 1452–1457

    Google Scholar 

  71. Miyazaki H, Yanagida N, Horinouchi S, Beppu T (1990). Specific excretion into the medium of a serine protease from Serratia marcescens. Agric Biol Chem, 54(10): 2763–2765

    CAS  Google Scholar 

  72. Mohankumar A, Raj R H K (2011). Production and characterization of Serratiopeptidase enzyme from Serratia marcescens. Int J Biol, 3(3): 39–44

    CAS  Google Scholar 

  73. Moriya N, Nakata M, Nakamura M, Takaoka M, Iwasa S, Kato K, Kakinuma A (1994). Intestinal absorption of serrapeptase (TSP) in rats. Biotechnol Appl Biochem, 20(Pt 1): 101–108

    CAS  PubMed  Google Scholar 

  74. Mundhava S G, Mehta D S, Thaker S J (2016). A Comparative Study to Evaluate Anti-Inflammatory and analgesic activity of commonly used Proteolytic Enzymes and their Combination with Diclofenac in Rats. Int J Pharm Sci Res, 7(6): 2615–2619

    CAS  Google Scholar 

  75. Nagaoka S, Tanaka M, Tsubura E (1979). A double blind clinical study on the expectorant effect of Seaprose-S. RinshoHyoka, 7: 205–232 (ClinEval)

    Google Scholar 

  76. Nageswara S, Singam R, Guntuku G (2016). Design of a low cost fermentation medium for the production of Serratiopeptidase enzyme by a novel Streptomyces sp. World J Pharm Pharm Sci, 5(10): 829–842

    CAS  Google Scholar 

  77. Nakahama K, Yoshimura K, Marumoto R, Kikuchi M, Lee I S, Hase T, Matsubara H (1986). Cloning and sequencing of Serratia protease gene. Nucleic Acids Res, 14(14): 5843–5855

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  78. Nakamura S, Hashimoto Y, Mikami M, Yamanaka E, Soma T, Hino M, Azuma A, Kudoh S (2003). Effect of the proteolytic enzyme serrapeptase in patients with chronic airway disease. Respirology, 8 (3): 316–320

    PubMed  Article  Google Scholar 

  79. Namdeo M, Bajpai S K (2009). Immobilization of a-amylase onto cellulose-coated magnetite (CCM) nanoparticles and preliminary starch degradation study. J MolCatalEnzym, 59: 134–139

    CAS  Google Scholar 

  80. Nieper H A (2010). “The Curious Man: The Life and Works of Dr. Hans Nieper”. AuthorHouse.

    Google Scholar 

  81. Okumura H, Watanabe R, Kotoura Y, Nakane Y, Tangiku O (1977). Effects of a proteolytic-enzyme preparation used concomitantly with an antibiotic in osteoarticular infections (author’s transl). Jpn J Antibiot, 30(3): 223–227

    CAS  PubMed  Google Scholar 

  82. Pakhale S V, Bhagwat S S (2016). Purification of serratiopeptidase from Serratiamarcescens NRRL B 23112 using ultrasound assisted three phase partitioning. Ultrasonics Sonochemistry, 31: 532–538

    CAS  PubMed  Article  Google Scholar 

  83. Panagariya A, Sharma A K (1999). A preliminary trial of serratiopeptidase in patients with carpal tunnel syndrome. J Assoc Physicians India, 47(12): 1170–1172

    CAS  PubMed  Google Scholar 

  84. Pansuriya R, Singhal R (2011). Effects of dissolved oxygen and agitation on production of serratiopeptidase by Serratia marcescens NRRL B-23112 in stirred tank bioreactor and its kinetic modeling. J Microbiol Biotechnol, 21(4): 430–437

    CAS  PubMed  Google Scholar 

  85. Pansuriya R C, Singhal R S (2010). Evolutionary operation (EVOP) to optimize whey independent serratiopeptidase production from Serratia marcescens NRRL B-23112. J Microbiol Biotechnol, 20 (5): 950–957

    CAS  PubMed  Article  Google Scholar 

  86. Patel J K, Thakkar D, Patel M B (2015). Development and Validation of Analytical Method for Estimation of Paracetamol, Lornoxicam and Serratiopeptidase in their Combined Dosage Form. J Pharm Sci Bioscientific Res, 5(5): 425–433

    Google Scholar 

  87. Pravin K S, Ravindra L B, Gaudb R S, Kiran N B, Madhugandha S K (2015). Modulation of serratiopeptidase transdermal patch by lipidbased transfersomes. J Adhes Sci Technol, 29(23): 2622–2633

    Article  CAS  Google Scholar 

  88. Queiroz B P V, Melo I S (2006). Antagonism of Serratiamarcescens towards Phytophthoraparasitica and its effects in promoting the growth of citrus. Braz J Microbiol, 37(4): 448–450

    Article  Google Scholar 

  89. Rajinikanth B, Venkatachalam V V, Manavalan R (2014). Investigations on the potential of serratiopeptidase–A proteolytic enzyme, on acetic acid induced ulcerative colitis in mice. Int J Pharm Pharm Sci, 6(5): 525–531

    Google Scholar 

  90. Rath G, Johal E S, Goyal A K (2011). Development of serratiopeptidase and metronidazole based alginate microspheres for wound healing. Artif Cells Blood Substit Immobil Biotechnol, 39(1): 44–50

    CAS  PubMed  Article  Google Scholar 

  91. Reddy A R, Rajamani K, Mounika A, Reddy G S (2015). Development and validation of RP-HPLC Method for simulations estimation of paracetamol, aceclofenac and serratiopeptidase in combined tablet dosage form. World J Pharm Pharm Sci, 4(3): 1008–1023

    CAS  Google Scholar 

  92. Robert S R (2009). The ‘Miracle’ Enzyme is Serrapeptase, the 2nd Gift from Silkworms Giving the answer to Pain, Inflammation and Clear Arteries. Naturally Healthy Publications, 3(4): 12–19

    Google Scholar 

  93. Romero F J, Garcia L A, Salas J A, Diaz M, Quiros L M (2001). Production, purification and partial characterization of two extracellular proteases from Serratia marcescens grown in whey. Process Biochem, 36(6): 507–515

    CAS  Article  Google Scholar 

  94. Ruell J A, Avdeef A, Du C, Tsinman K (2002). A Simple PAMPA Filter for Passively Absorbed Compounds. 224th National Meeting of the American Chemical Society.

    Google Scholar 

  95. Sabu A (2003).Sources, Properties and Applications of Microbial Therapeutics Enzymes. Indian J Biotechnol, 2(3): 334–341

    CAS  Google Scholar 

  96. Salamone P R, Wodzinski R J (1997). Production, purification and characterization of a 50-kDa extracellular metalloprotease from Serratia marcescens. Appl Microbiol Biotechnol, 48(3): 317–324

    CAS  PubMed  Article  Google Scholar 

  97. Salarizadeh N, Hasannia S, Noghabi K A, Sajedi R H (2014). Purification and Characterization of 50 kDa Extracellular Metalloprotease from Serratia sp. ZF03. Iranian J Biotechnol, 12(3): 18–27

    Article  Google Scholar 

  98. Sandhya K V, Devi S G, Mathew S T (2008). Quantitation of serrapeptase in formulations by UV method in the microplate format. Curr Drug Deliv, 5(4): 303–305

    CAS  PubMed  Article  Google Scholar 

  99. Sasaki S, Kawanami R, Motizuki Y, Nakahara Y, Kawamura T, Tanaka A, Watanabe S (2000). Serrapeptase-induced lung injury manifesting as acute eosiniphilic pneumonia. Nihon Kokyuki Gakkai Zasshi, 38 (7): 540–544

    CAS  PubMed  Google Scholar 

  100. Selan L, Papa R, Tilotta M, Vrenna G, Carpentieri A, Amoresano A, Pucci P, Artini M (2015). Serratiopeptidase: a well-known metalloprotease with a new non-proteolytic activity against S. aureus biofilm. BMC Microbiol, 15(1): 207

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  101. Sellman S (2003). Serrapeptase, An Amazing Gift from The Silk Worm. World rights reserved.

    Google Scholar 

  102. Shanks R M, Stella N A, Hunt K M, Brothers K M, Zhang L, Thibodeau P H (2015). Identification of SlpB, a Cytotoxic Protease from Serratia marcescens. Infect Immun, 83(7): 2907–2916

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  103. Shimura S, Okubo T, Maeda S, Aoki T, Tomioka M, Shindo Y, Takishima T, Umeya K (1983). Effect of expectorants on relaxation behavior of sputum viscoelasticity in vivo. Biorheology, 20(5): 677–683

    CAS  PubMed  Article  Google Scholar 

  104. Singh R, Kumar M, Mittal A, Mehta P K (2016). Microbial enzymes: industrial progress in 21st century. 3 Biotech, 6(2): 174

    PubMed  PubMed Central  Article  Google Scholar 

  105. Stancu M M (2016). Response Mechanisms in Serratia marcescens IBBPo15 During Organic Solvents Exposure. Curr Microbiol, 73(6): 755–765

    CAS  PubMed  Article  Google Scholar 

  106. Subbaiya R, Ayyappadasan G, Mythili S V, Dhivya E, Ponmurugan P (2011). Pilot scale microbial production and optimization of Serratia peptidase from Serratia marcescens. J Ecobiotechnol, 3(12): 10–13

    CAS  Google Scholar 

  107. Tachibana M, Mizukoshi O, Harada Y, Kawamoto K, Nakai Y (1984). A multi-centre, double-blind study of serrapeptase versus placebo in post-antrotomy buccal swelling. Pharmatherapeutica, 3(8): 526–530

    CAS  PubMed  Google Scholar 

  108. Tao K, Yu X, Liu Y, Shi G, Liu S, Hou T (2007). Cloning, expression, and purification of insecticidal protein Pr596 from locust pathogen Serratia marcescens HR-3. Curr Microbiol, 55(3): 228–233

    CAS  PubMed  Article  Google Scholar 

  109. Tripura C, Sashidhar B, Podile A R (2007). Ethyl methanesulfonate mutagenesis-enhanced mineral phosphate solubilization by groundnut-associated Serratia marcescens GPS-5. Curr Microbiol, 54(2): 79–84

    CAS  PubMed  Article  Google Scholar 

  110. Tsuyama N, Yoshio O, Makoto F (1977). Clinical evaluation on antiswelling drug-A-4700 in orthopaedic field. A comprehensive double blind controlled trial compared with serratiopeptidase and placebo in 20 orthopedic clinics. RinshoHyoka, 5: 535–575 (ClinEval)

    Google Scholar 

  111. UmaMaheswari T, Hemalatha T, Sankaranarayanan P, Puvanakrishnan R (2016). Enzyme therapy: current perspectives. Indian J Exp Biol, 54(1): 7–16

    PubMed  Google Scholar 

  112. Vanama J, Chintada H, Guntuku G, Tadimalla P (2014). Application of response surface methodology in medium components optimization to enhance serratiopeptidase production by Streptomyces hydrogenans MGS13. Eur Sci J, 10(12): 1857–7431

    Google Scholar 

  113. Verma M L, Barrow C J, Puri M (2013). Nanobiotechnology as a novel paradigm for enzyme immobilisation and stabilisation with potential applications in biodiesel production. Appl Microbiol Biotechnol, 97 (1): 23–39

    CAS  PubMed  Article  Google Scholar 

  114. Vicari E, La Vignera S, Battiato C, Arancio A (2005). Treatment with non-steroidal anti-inflammatory drugs in patients with amicrobial chronic prostato-vesiculitis: transrectal ultrasound and seminal findings. Minerva Urol Nefrol, 57(1): 53–59

    CAS  PubMed  Google Scholar 

  115. Viswanatha Swamy A H, Patil P A (2008). Effect of some clinically used proteolytic enzymes on inflammation in rats. Indian J Pharm Sci, 70 (1): 114–117

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  116. Wagdarikar J M, Joshi A M, Shaikh A A (2015). Media Optimization Studies for Enhanced Production of Serratiopeptidase from Bacillus Licheniformis (NCIM 2042). Asian Journal of Biomedical and Pharmacutical Sciences, 5(42): 19–23

    CAS  Article  Google Scholar 

  117. Woodley J F (1994). Enzymatic barriers for GI peptide and protein delivery. Crit Rev Ther Drug Carrier Syst, 11(2-3): 61–95

    CAS  PubMed  Google Scholar 

  118. Yu C C, Kuo Y Y, Liang C F, ChienW T, Wu H T, Chang T C, Jan F D, Lin C C (2012). Site-specific immobilization of enzymes on magnetic nanoparticles and their use in organic synthesis. Bioconjug Chem, 23 (4): 714–724

    CAS  PubMed  Article  Google Scholar 

  119. Zhu H, Pan J, Hu B, Yu H L, Xu J H (2009). Immobilization of glycolate oxidase from Medicago falcata on magnetic nanoparticles for application in biosynthesis of glyoxylic acid. J Mol Catal, B Enzym, 61(3–4): 174–179

    CAS  Article  Google Scholar 

  120. Ziv-Polat O, Topaz M, Brosh T, Margel S (2010). Enhancement of incisional wound healing by thrombin conjugated iron oxide nanoparticles. Biomaterials, 31(4): 741–747

    CAS  PubMed  Article  Google Scholar 

Download references

Acknowledgements

The authors would like to thank SRM University, Chennai, India for supporting and performing the study. SG is obliged to the management of SRM for partial completion of masters in Genetic Engineering.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Selvarajan Ethiraj.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ethiraj, S., Gopinath, S. Production, purification, characterization, immobilization, and application of Serrapeptase: a review. Front. Biol. 12, 333–348 (2017). https://doi.org/10.1007/s11515-017-1461-3

Download citation

Keywords

  • Serrapeptase
  • proteolytic enzyme
  • anti-inflammatory
  • fibrinolytic